| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.002 | 0.9 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.0044 | 1 |